CVD 909 Vi Prime Boost Study

NCT00326443 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Typhoid Fever

Interventions

BIOLOGICAL: CVD 909
DRUG: Placebo
BIOLOGICAL: Vi Polysaccharide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)